Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
NGM Biopharmaceuticals, Inc
MacroGenics
BioNTech SE
Cancer Research and Biostatistics Clinical Trials Consortium
Ludwig Institute for Cancer Research
Genmab
National Institutes of Health Clinical Center (CC)
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Seagen Inc.
SCRI Development Innovations, LLC
Gilead Sciences
M.D. Anderson Cancer Center
Seagen Inc.
National Cancer Institute (NCI)
University of Wisconsin, Madison
Western Regional Medical Center
Memorial Sloan Kettering Cancer Center
Duke University